Fig. 1: Abnormal activation of HECTD3 in gastric cancer leads to poor prognosis for patients. | Cell Death Discovery

Fig. 1: Abnormal activation of HECTD3 in gastric cancer leads to poor prognosis for patients.

From: HECTD3 promotes gastric cancer progression by mediating the polyubiquitination of c-MYC

Fig. 1

A, B Expression of HECTD3 in gastric cancer and many other tumor types was determined using the TIMER2 (http://timer.cistrome.org/) and GEPIA (http://gepia.cancer-pku.cn/index.html) databases. C Protein Atlas database (http://www.proteinatlas.org/) was adopted to check expression of HECTD3 in human nontumor gastric mucosa and gastric cancer. D, E The R2 database and Kaplan–Meier plotter were applied to detect prognostic significance of HECTD3. F The expression of HECTD3 was analyzed through the UALCAN database.

Back to article page